NL-OMON36023
Completed
Not Applicable
The contribution of the sympathetic nervous system to the anabolic effect of estrogen on bone. - E2Bone
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- osteoporosis
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •last menstrual cycle 12\-60 months ago
Exclusion Criteria
- •Contraindications to HRT, beta\-agonist or beta\-antagonist treatment, such as cardiovascular disease, astma, COPD, renal or hepatic insufficiency
- •Any medication or disease influencing bone turnover
- •Prior VTE or breast cancer
- •Current osteoporosis defined by a DXA Z\-score \>\-2\.5
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The nervous system, estrogen and osteoporosis.osteoporosis, osteoporoseNL-OMON25589Academic Medical Center32
Completed
Not Applicable
Assessment of the sympathetic nervous system blockade of the upper limb after a brachial plexus block in patients receiving haemodialysisISRCTN82322174ottingham University Hospitals NHS Trust (UK)30
Completed
Not Applicable
Cardiac sympathetic nervous system function and activity as a predictor for appropriate ICD therapy in patients with chronic heart failureheart failure and fatal arrhytmiassudden cardiac death10007521NL-OMON33730Academisch Medisch Centrum300
Completed
Not Applicable
Impact of the cardiac sympathetic nerve function by atrial fibrillation catheter ablatioparoxysmal atrial fibrillationJPRN-UMIN000016638Kansai Rosai Hospital50
Completed
Not Applicable
Are the sympathetic sensorimotor changes induced by thoracic epidural anaesthesia such that mobilization is possible?ISRCTN74560140Record Provided by the NHSTCT Register - 2006 Update - Department of Health80